Invenshure

Invenshure is a Minneapolis, Minnesota-based venture studio and catalyst that builds, funds, and scales technology and biotech companies from novel institutional intellectual property. The firm partners with scientists and research institutions, including Mayo Clinic and Parker Hannifin, to commercialize disruptive technologies in healthcare, biotech, and related fields such as genomics, diagnostics, and precision medicine. Invenshure operates by raising venture funds to invest in and support its portfolio companies, which have included Exosite, Imbio, OneOme, and Flywheel. In January 2022, the firm raised $6 million in funding led by Great North Ventures and The IPO Group, contributing to an estimated total raise of $5.1 million to $6 million. It reports approximately $21.3 million in revenue and maintains an employee count of 36-45. Invenshure was founded in 2011 by Troy Kopischke.